MedTrace Logo

Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid

NCT01974297 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 194

Last updated 2013-11-04

No results posted yet for this study

Summary

The purpose of this study is to compare combination atorvastatin/fenofibric acid 10/135mg with atorvastatin 20mg monotherapy in the mixed hyperlipidemia who were not at lipid goals with atorvastatin 10mg monotherapy.

Conditions

  • Mixed Hyperlipidemia

Interventions

DRUG

Atorvastatin 10mg, fenofibric acid 135mg

Atorvastatin 10mg, fenofibric acid 135mg/day PO for 12 weeks

DRUG

atorvastatin 20mg

Atorvastatin 20mg/day PO for 12weeks

Sponsors & Collaborators

  • Sang Hak Lee

    lead OTHER

Principal Investigators

  • Sang-Hak Lee, PhD · Severance Hospital, Yonsei University College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-06-30
Completion
2014-07-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01974297 on ClinicalTrials.gov